-transparent.png){kind=logo}
Twenty-one patients with angina pectoris took part in a double-blind cross-over comparison of alprenolol (an adrenergic beta-blocker), pentanitrol (pentaerythritol tetranitrate), and placebo. Two-thirds of the patients were clinically improved on alprenolol 100 mg. four times daily, which was found to be significantly better than pentanitrol 30 mg. four times daily and placebo. There was also an indication of reduced severity of anginal attacks during alprenolol therapy. It is concluded that success in at least two-thirds can be expected with alprenolol. No serious complications or side-effects occurred during alprenolol treatment.
Related Publications
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
January 1981,
Arzneimittel-Forschung,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
August 1970,
The Medical journal of Australia,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
July 1971,
American heart journal,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
October 1974,
Annals of clinical research,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
April 1970,
Japanese circulation journal,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
July 1971,
British heart journal,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
August 1980,
European heart journal,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
March 1971,
JAMA,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
April 1972,
JAMA,
A Aubert, and
G Nyberg, and
R Slaastad, and
L Tjeldflaat
November 1972,
The Journal of the Association of Physicians of India,
